2020
DOI: 10.1002/adtp.202000025
|View full text |Cite
|
Sign up to set email alerts
|

Parathyroid Hormone‐Loaded Microneedle Promotes Tendon Healing Through Activation of mTOR

Abstract: Tendon rupture/defects may impose a huge economic and mental burden on patients and society. At present, neither surgery nor conservative treatment regimens can provide long‐term therapeutic benefits, and the prognosis is often disappointing owing to the loss of tendon function and strength. There is an urgent need for innovative strategies to treat defective tendons. Here, a microneedle patch is developed for the efficient transdermal delivery of parathyroid hormone (PTH). The microneedle tip is made up of po… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 59 publications
0
3
0
Order By: Relevance
“…This enabled sustained release of parathyroid hormone for 24 h in mice in vivo. [ 63 ] Using a similar strategy, a group utilized PVA based MNAs containing a long‐acting PVP/PEG‐based NPs loaded with rilpivirine (RPV), to provide a more acceptable choice for treatment of HIV. Based on the results of in vivo studies the MNAs could maintain effective RPV plasma levels over 7 d in humans.…”
Section: Mnas Enable Controlled‐release Mechanismsmentioning
confidence: 99%
“…This enabled sustained release of parathyroid hormone for 24 h in mice in vivo. [ 63 ] Using a similar strategy, a group utilized PVA based MNAs containing a long‐acting PVP/PEG‐based NPs loaded with rilpivirine (RPV), to provide a more acceptable choice for treatment of HIV. Based on the results of in vivo studies the MNAs could maintain effective RPV plasma levels over 7 d in humans.…”
Section: Mnas Enable Controlled‐release Mechanismsmentioning
confidence: 99%
“…For example, PVA, a swellable polymer, was used to fabricate MNAs. This enabled sustained release of parathyroid hormone for 24h in mice in vivo 63 . Using a similar strategy, a group utilized PVA based MNAs containing a long-acting PVP/PEG based NPs loaded with rilpivirine (RPV), to provide a more acceptable choice for treatment of HIV.…”
Section: Mnas Enable Sustained Release Of Cargomentioning
confidence: 99%
“…[46] Based on this, Yao et al developed hydrogel microneedles with PVA needles containing parathyroid hormone (PTH). [48] PTH is a systemic hormone exhibiting a positive impact on tendon bone healing process. [49,50] The PVA-based hydrogel microneedles were fabricated using the freezing-thawing method, [51] keeping PTH from denaturing.…”
Section:  Repairing Defective Connective Tissuesmentioning
confidence: 99%